|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.300 USD | -0.76% |
|
+3.17% | -22.16% |
| 06-29 | Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 2000 Index | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Neutral |
| Resistance | 1.35 | 1.46 | 1.92 |
| Spread/Res. | -3.70% | -10.96% | -32.29% |
| Spread/Supp. | +3.17% | +9.24% | +32.06% |
| Support | 1.26 | 1.19 | 0.9844 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
